TCM product approved for sale in Singapore
By Zhang Yu in Shijiazhuang |
chinadaily.com.cn |
Updated: 2020-05-07 15:56
Share
Share - WeChat
Applications for registration in more countries are underway, including countries in the Middle East, Africa and Latin America, the company said.
Lianhua Qingwen was recommended in four versions of a treatment plan from the National Health Commission for treating COVID-19, the pneumonia associated with the novel coronavirus.
On April 12, the National Medical Products Administration approved adding mild symptoms of COVID-19 as indications for which Lianhua Qingwen is effective.
- Reflective New Year festivities grow popular
- Probe identifies cause of tragic Hebei nursing home fire
- Safety breaches, substandard materials, management failures caused Fuzhou accident: report
- Cutting edge UAV completes maiden flight in Sichuan
- Hainan registers record flow of foreign visitors
- Hebei discovery sheds light on development of Stone Age tools
